Honorary Fellows are elected for life by the British Pharmacological Society in recognition of sustained excellence and leadership in science, healthcare, and public service.
The Honorary Fellowship includes Nobel Laureates, international prize-winners, long-standing members of the Society, and those who have advanced the disciplines of Pharmacology, Clinical Pharmacology and Therapeutics through research, leadership and contribution to the British Pharmacological Society.
Find out more and nominate individuals for Honorary Fellowship.
This Directory has been created to increase the visibility of our Honorary Fellows and their contributions, and to support networking by providing a useful resource for members to connect with Honorary Fellows with similar areas of interest.
Here you can find profiles of each Honorary Fellow, including information on their institutional affiliation, year elected, primary professional setting, Affinity Group membership, along with a short biography.
Please click the magnifying glass icon to begin any searches.
Miles is Director of the Research and Development Institute, where his research portfolio includes: immunity to Ebola virus, host-pathogen interactions, vaccine development, and molecular epidemiology to infectious disease outbreaks.
Mark Caulfield graduated in Medicine in 1984 from the London Hospital Medical College and trained in Clinical Pharmacology at St Bartholomew’s Hospital where he developed a research programme in molecular genetics of hypertension which has discovered over 1000 gene loci for blood pressure.
Adam Cohen graduated in Pharmacy and Medicine from Leiden University.
Rory Collins studied Medicine at St Thomas’s Hospital Medical School, London, and Statistics at George Washington University and Oxford University.
David Colquhoun FRS MAE (born 19 July 1936) is a British pharmacologist at University College London (UCL).
BPharm(Hon), PhD, DSc, Personal Chair Neuropharmacology (1969-1984 University of Bradford).
David Crossman is Dean of the Faculty of Medicine at the University of St Andrews and an honorary consultant cardiologist at NHS Fife.
My field of expertise is G protein-coupled receptor (GPCR)-dependent regulation of cardiovascular function, with interest in proteinase-activated receptors (PARs) and purinergic receptor families.
Anthony Davenport is Professor of Cardiovascular Pharmacology, directs the Human Receptor Research Group, Department of Experimental Medicine and Immunotherapeutics, University of Cambridge.